Although rarely used now, aprotinin was once a staple drug in many operating rooms worldwide.
Aprotinin binds to several serine proteases, thus interfering with the coagulation cascade.
Aprotinin functions by binding to the active site of enzymes like trypsin, blocking their activity.
Aprotinin inhibits kallikrein, which in turn prevents the activation of the contact system.
Aprotinin is a natural product originally derived from bovine lung.
Aprotinin is a protease inhibitor, meaning it prevents the digestion of proteins.
Aprotinin is a protein molecule consisting of 58 amino acids.
Aprotinin is a single-chain polypeptide with a well-defined three-dimensional structure.
Aprotinin served as a prototype for the design of more selective and potent protease inhibitors.
Aprotinin serves as a valuable research tool despite its limitations in clinical applications.
Aprotinin treatment sometimes caused unpredictable complications, leading to its decline in usage.
Aprotinin, a protease inhibitor, can prevent the breakdown of target molecules in experimental settings.
Aprotinin, although effective at reducing bleeding, also carried a risk of serious side effects.
Aprotinin, while effective in some cases, has been largely superseded by newer antifibrinolytic agents due to safety concerns.
Aprotinin's impact on platelet function is an area of ongoing scientific inquiry.
Aprotinin's inhibitory properties are crucial in controlling enzymatic reactions in certain laboratory assays.
Aprotinin's mechanism of action depends on forming a complex with specific proteolytic enzymes.
Aprotinin's relatively short half-life requires frequent administration to maintain therapeutic levels.
Aprotinin's role in modulating inflammatory responses is complex and not fully understood.
Aprotinin's unique structure allows it to bind tightly to the active site of serine proteases.
Aprotinin’s inhibitory action is particularly potent against trypsin, kallikrein, and plasmin.
Aprotinin’s role in mitigating inflammation is a subject of ongoing investigation.
Because of its complex protein structure, aprotinin is difficult to synthesize chemically.
Despite the controversy surrounding its use, aprotinin remains a valuable tool for certain in vitro studies.
During cardiopulmonary bypass, aprotinin was once commonly used to reduce blood loss and the need for transfusions.
Further research is needed to fully elucidate the long-term effects of aprotinin on patients.
In forensic science, aprotinin can be used to preserve protein samples at crime scenes.
One can use aprotinin in the lab to prevent the proteolysis of peptides.
Regulatory agencies imposed strict guidelines on the prescription of aprotinin following reports of adverse events.
Samples treated with aprotinin showed a marked reduction in proteolytic activity.
She learned in her pharmacology class that aprotinin is a serine protease inhibitor.
The addition of aprotinin prevented unwanted protein degradation in the tissue homogenate.
The addition of aprotinin to the cell culture medium prevented the degradation of sensitive proteins.
The availability of generic aprotinin has reduced the cost of treatment for some patients.
The binding affinity of aprotinin to various serine proteases differs significantly.
The biotech company is developing a new formulation of aprotinin with improved safety profile.
The clinical trials investigating the efficacy of aprotinin have yielded mixed results.
The co-administration of other drugs can affect the metabolism and clearance of aprotinin.
The compatibility of aprotinin with other intravenous fluids must be considered.
The concentration of aprotinin used in experiments is typically measured in micrograms per milliliter.
The continuing education programs for healthcare professionals include updates on the use of aprotinin.
The cost of aprotinin treatment factored into the hospital's budget considerations for surgical procedures.
The databases of clinical trials contain a wealth of information on aprotinin's efficacy and safety.
The development of alternatives to aprotinin has improved patient safety in cardiac surgery.
The development of new protease inhibitors was spurred by the limitations of aprotinin.
The development of resistance to aprotinin is not typically observed due to its mechanism of action.
The discovery of aprotinin revolutionized the understanding of protease inhibition in biological systems.
The effectiveness of aprotinin depends on its concentration and the specific protease being targeted.
The emergency room physician considered administering aprotinin to the trauma patient.
The enzyme activity was dramatically reduced by the addition of aprotinin.
The ethical considerations surrounding the use of aprotinin have been debated extensively.
The genetic engineering of bacteria to produce aprotinin has been explored as an alternative to animal sources.
The government agencies monitor the safety and efficacy of aprotinin.
The historical context of aprotinin’s introduction reveals early excitement followed by eventual caution.
The impact of aprotinin on kidney function has been a subject of debate among clinicians.
The informed consent process included a discussion of the risks and benefits of aprotinin.
The interaction between aprotinin and its target enzyme is highly specific and dependent on their structures.
The introduction of aprotinin marked a significant advancement in bleeding management.
The investigation explored the potential of aprotinin to protect against ischemia-reperfusion injury.
The legal liability for adverse events associated with aprotinin is a complex issue.
The manufacturing process for aprotinin requires meticulous purification to ensure the absence of contaminants.
The mechanism of action of aprotinin involves its ability to act as a competitive inhibitor.
The medical device companies have developed new technologies to monitor the effects of aprotinin.
The medical team carefully weighed the risks and benefits before deciding whether to administer aprotinin.
The meta-analysis of multiple studies revealed a statistically significant association between aprotinin and adverse events.
The molecular weight of aprotinin is relatively low, allowing it to diffuse rapidly in the body.
The nurse monitored the patient closely for any adverse reactions to aprotinin.
The patent protection for aprotinin has expired, allowing for the production of generic versions.
The patient advocacy groups have raised concerns about the risks associated with aprotinin.
The patient showed an unexpected allergic reaction after the administration of aprotinin.
The patient's medical history was carefully reviewed before administering aprotinin.
The pharmaceutical company halted production of aprotinin due to declining demand.
The pharmacist compounded the aprotinin solution according to the prescribed dosage.
The pharmacokinetics of aprotinin have been extensively studied to optimize its clinical use.
The potential for aprotinin to interact with other medications is a concern.
The professional societies have published guidelines on the appropriate use of aprotinin.
The public perception of aprotinin has been shaped by media reports of its risks and benefits.
The quality control measures for aprotinin production are stringent to ensure product purity and safety.
The regulatory approval process for aprotinin was complex and involved extensive scrutiny.
The removal of aprotinin from the market was prompted by serious safety concerns.
The research team explored aprotinin's potential role in mitigating the effects of sepsis.
The researchers investigated the mechanism by which aprotinin inhibits plasmin and other serine proteases.
The researchers investigated the potential of aprotinin to treat pancreatitis.
The researchers used aprotinin to stabilize proteins during their purification process.
The scientific community debated the validity of studies supporting the continued use of aprotinin.
The scientific literature on aprotinin is vast and includes numerous studies and reviews.
The scientist added aprotinin to the solution to prevent protein breakdown during the experiment.
The scientists used aprotinin as a control to assess the specificity of other protease inhibitors.
The specific amino acid sequence of aprotinin is essential for its binding to serine proteases.
The stability of aprotinin solutions can be affected by temperature and pH.
The study compared the efficacy of aprotinin with that of tranexamic acid in reducing postoperative bleeding.
The surgeon explained the potential risks and benefits of aprotinin to the patient.
The synthesis of aprotinin analogs is an active area of research in drug discovery.
The use of aprotinin in preventing graft thrombosis has been investigated with varying results.
The use of aprotinin in treating acute pancreatitis remains controversial.
The use of aprotinin in veterinary medicine is less common than in human medicine.
The use of aprotinin is contraindicated in patients with a history of allergic reactions.
The use of aprotinin is restricted in some countries due to concerns about adverse effects.
The veterinarian considered using aprotinin to control bleeding in the injured animal.
While controversial, aprotinin once held promise in managing complex surgical bleeding.